Search

Your search keyword '"Weitzel, J.N."' showing total 120 results

Search Constraints

Start Over You searched for: Author "Weitzel, J.N." Remove constraint Author: "Weitzel, J.N."
120 results on '"Weitzel, J.N."'

Search Results

1. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

3. 1850P Communication patterns and cascade testing among pathogenic variant carriers

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

10. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

11. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

12. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

13. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

14. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

15. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

16. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.

17. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

18. Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

19. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

20. The founder mutation MSH2*1906G [right arrow] C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population

22. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

23. Shared heritability and functional enrichment across six solid cancers.

24. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

25. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

26. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

29. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

30. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

31. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

32. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

33. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

34. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

35. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

36. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

37. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

38. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

39. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

40. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

41. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

47. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

48. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

49. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

50. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

Catalog

Books, media, physical & digital resources